Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.115561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Tomonori Oka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cancer Immunology and Cutaneous Biology Research Center, Department of Dermatology and Krantz Family Center for Cancer Research, Massachus…. Hauptthemen laut MEDLINE: Skin Neoplasms, Basal Cell Carcinoma, Mutation, Epigenomics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, Burroughs Wellcome Fund, LEO Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Cancer Immunology and Cutaneous Biology Research Center, Department of Dermatology and Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
- Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
- Dermatology Section, Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
- Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
- Center for Cancer Immunology and Cutaneous Biology Research Center, Department of Dermatology and Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Dep…
Förderung
- NIAMS NIH HHS
- Burroughs Wellcome Fund
- LEO Foundation
- Society for Pediatric Dermatology
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Oka, T., Smith, S. S., Oliver-Garcia, V. S., Lee, T., Son, H. G., Mortaja, M., Azin, M., Garza-Mayers, A. C., Huang, J. T., Nazarian, R. M., Horn, T. D., & Demehri, S. (2025). Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115561
Vancouver
Oka T, Smith SS, Oliver-Garcia VS, Lee T, Son HG, Mortaja M, et al. Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115561
BibTeX
@article{Oka2025,
author = {Oka, Tomonori and Smith, Sabrina S and Oliver-Garcia, Valeria S and Lee, Truelian and Son, Heehwa G and Mortaja, Mahsa and Azin, Marjan and Garza-Mayers, Anna C and Huang, Jennifer T and Nazarian, Rosalynn M and Horn, Thomas D and Demehri, Shadmehr},
title = {Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.115561}
}
EUVIMED